These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22339217)

  • 1. Current immunotherapy of multiple sclerosis and future challenges: relevance of immune-mediated repair.
    Carrithers MD
    Curr Pharm Biotechnol; 2012 Jun; 13(8):1409-17. PubMed ID: 22339217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Immunotherapy of Multiple Sclerosis and Future Challenges: Relevance of Immune-mediated Repair.
    Carrithers MD
    Curr Pharm Biotechnol; 2012 Feb; ():. PubMed ID: 22339218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and treatment trials in multiple sclerosis.
    Kieseier BC; Wiendl H; Hemmer B; Hartung HP
    Curr Opin Neurol; 2007 Jun; 20(3):286-93. PubMed ID: 17495622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunistic infections and other risks with newer multiple sclerosis therapies.
    Berger JR; Houff S
    Ann Neurol; 2009 Apr; 65(4):367-77. PubMed ID: 19399841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system infections - a potential complication of systemic immunotherapy.
    Hemmer B; Frohman E; Hartung HP; Stüve O
    Curr Opin Neurol; 2006 Jun; 19(3):271-6. PubMed ID: 16702834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current immunotherapy of multiple sclerosis].
    Paul F; Ruprecht K
    Nervenarzt; 2015 Aug; 86(8):1031-42; quiz 1043-4. PubMed ID: 26253589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic perspectives in multiple sclerosis].
    Lubetzki C
    Rev Prat; 2006 Jun; 56(12):1347-52. PubMed ID: 16948223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific treatment of multiple sclerosis.
    Silberberg DH
    Clin Neurosci; 1994; 2(3-4):271-4. PubMed ID: 7749898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis: interferon beta for some serious forms.
    Prescrire Int; 2007 Dec; 16(92):252-7. PubMed ID: 18092425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviews.
    Clerico M; Rivoiro C; Contessa G; Viglietti D; Durelli L
    Clin Neurol Neurosurg; 2008 Nov; 110(9):878-85. PubMed ID: 18164542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future research directions in multiple sclerosis therapies.
    Greenberg BM; Calabresi PA
    Semin Neurol; 2008 Feb; 28(1):121-7. PubMed ID: 18256992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concepts of induction and escalation therapy in multiple sclerosis.
    Rieckmann P
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S42-5. PubMed ID: 19200866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in the treatment of multiple sclerosis?].
    Tackenberg B; Himmerich H; Wellek A; Oertel WH; Sommer N
    MMW Fortschr Med; 2007 May; 149 Suppl 2():51-5. PubMed ID: 17724968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern multiple sclerosis treatment - what is approved, what is on the horizon.
    Pilz G; Wipfler P; Ladurner G; Kraus J
    Drug Discov Today; 2008 Dec; 13(23-24):1013-25. PubMed ID: 18775508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowns and unknowns in the future of multiple sclerosis treatment.
    Stüve O
    J Neurol Sci; 2009 Dec; 287 Suppl 1():S30-6. PubMed ID: 20106346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for multiple sclerosis: current and emerging therapies.
    Gawronski KM; Rainka MM; Patel MJ; Gengo FM
    Pharmacotherapy; 2010 Sep; 30(9):916-27. PubMed ID: 20795847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy for multiple sclerosis.
    Weiner HL; Hohol MJ; Khoury SJ; Dawson DM; Hafler DA
    Neurol Clin; 1995 Feb; 13(1):173-96. PubMed ID: 7739502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of multiple sclerosis.
    Weiner HL; Hafler DA
    Ann Neurol; 1988 Mar; 23(3):211-22. PubMed ID: 3288084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current evidence and therapeutic strategies for multiple sclerosis.
    Wingerchuk DM
    Semin Neurol; 2008 Feb; 28(1):56-68. PubMed ID: 18256987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.